论文信息 - Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial - 字舞流文

Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial

M. Kersten | K. Nasserinejad | M. Dimopoulos | L. Tick | M. Gavriatopoulou | M. Kap | D. Deeren | J. Doorduijn | F. Offner | M. Minnema | S. Pals | M. Chamuleau | K. Amaador | J. Vos | E. Kastritis | L. Bohmer | Roberto D. K. Liu